Revista nº 814

Revueltas-Jiménez F, et al. | Cardiopatía isquémica y mujer 279 Actual Med. 2021; 106(814): 271- 279 38. Oosenbrug E, Marinho RP, Zhang J, Marzolini S, Colella TJF, Pakosh M, et al. Sex Differences in Cardiac Reha- bilitation Adherence: A Meta-analysis. Canadian Jour- nal of Cardiology. 2016;32(11):1316-24. DOI: 10.1016/j. cjca.2016.01.036 39. Scott LA, Ben-Or K, Allen JK. Why are women missing from outpatient cardiac rehabilitation programs? A review of multilevel factors affecting referral, enrollment, and com- pletion. J Womens Health (Larchmt). 2002;11(9):773-91. doi: 10.1089/15409990260430927. 40. Alfonso F, Bermejo J, Segovia J.. Revista Española de Cardiología 2005: actividad y reconocimiento científico. Rev Esp Cardiol, 58 (2005), pp. 1482-7 41. Guía ESC 2017 sobre el tratamiento del infarto agu- do de miocardio en pacientes con elevación del seg- mento ST [Internet]. [citado 28 de octubre de 2020]. Disponible en: https://www.revespcardiol.org/es- pdf-S0300893217306693 42. Antithrombotic Trialists’ (ATT) Collaboration, Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., Peto, R., Buring, J., Hennekens, C., Kearney, P., Meade, T., Patrono, C., Roncaglioni, M. C., & Zanchetti, A. Aspirin in the primary and secondary prevention of vascular disease: collabo- rative meta-analysis of individual participant data from randomised trials. The Lancet. 2009;373(9678):1849-60. DOI: 10.1016/S0140-6736(09)60503-1 43. Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jo- nes JB, et al. The Relative Efficacy and Safety of Clo- pidogrel in Women and Men: A Sex-Specific Collabo- rative Meta-Analysis. Journal of the American College of Cardiology. 2009;54(21):1935-45. DOI: 10.1016/j. jacc.2009.05.074 44. Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, et al. The efficacy of ticagrelor is maintained in wo- men with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2014;35(23):1541- 50. DOI: 10.1093/eurheartj/ehu075 45. Truong Quynh A., Murphy Sabina A., McCabe Carolyn H., Armani Annemarie, Cannon Christopher P. Benefit of Intensive Statin Therapy in Women. Circulation: Cardio- vascular Quality and Outcomes. 2011;4(3):328-36. DOI: 10.1161/CIRCOUTCOMES.110.957720 46. Hsue PY, Bittner VA, Betteridge J, Fayyad R, Laskey R, Wenger NK, et al. Impact of Female Sex on Lipid Lowe- ring, Clinical Outcomes, and Adverse Effects in Ator- vastatin Trials. The American Journal of Cardiology. 2015;115(4):447-53. DOI: 10.1016/j.amjcard.2014.11.026 47. Prevention of Cardiovascular Events and Death with Pra- vastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels. New England Journal of Medicine. 1998;339(19):1349-57. DOI: 10.1056/ NEJM199811053391902 48. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Try- nosky K, Diercks DB, et al. Gender disparities in the diag- nosis and treatment of non–ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angi- na Patients Suppress Adverse Outcomes With Early Imple- mentation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improve- ment Initiative. Journal of the American College of Cardio- logy. 2005;45(6):832-7. DOI: 10.1016/j.jacc.2004.11.055 49. Salas Coronas J, Montiel Trujillo A, López Martínez A, Zambrana García JL, Delgado Fernández M, Díez García F. Factores que intervienen en la no prescripción de betablo- queantes en los pacientes con infarto agudo de miocardio. Anales de Medicina Interna. 2001;18(4):23-6. 50. Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, et al. Gender and Acute Myocar- dial Infarction: Is There a Different Response to Throm- bolysis? Journal of the American College of Cardiology. 1997;29(1):35-42. DOI: 10.1016/S0735-1097(96)00449-4 51. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O’Keefe J, et al. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarc- tion. The American Journal of Cardiology. 1995;75(15):987- 92. DOI: 10.1016/S0002-9149(99)80709-7 52. Tamis-Holland JE, Palazzo A, Stebbins AL, Slater JN, Bo- land J, Ellis SG, et al. Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO II-B) Angioplas- ty Substudy. American Heart Journal. 2004;147(1):133-9. DOI: 10.1016/j.ahj.2003.06.002 Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. CONFLICTO DE INTERESES Si desea citar nuestro artículo: Revueltas-Jiménez F, Pleguezuelos-Ventura Á, Martínez-Mon- toya FJ, Delgado-Barrios C, Redruello-Guerrero P. ¿Se comporta la miocardiopatía isquémica diferente en las mujeres? Un acer- camiento holístico a esta patología en este sexo. Actual Med. 2021; 106(814):2 71-279. DOI: 10.15568/am.2021.814. rev01